Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Phoenix, Arizona 85044


Purpose:

The objective of this study was to assess the bioequivalence of a potential generic 6-mercaptopurine 50 mg tablet formulation compared with GlaxoSmithKline Purinethol® (mercaptopurine) 50-mg scored tablets following a single 50 mg oral dose administered in the fasted state.


Criteria:

Inclusion Criteria: - No clinically significant abnormal findings on physical examination, medical history, or clinical laboratory results. - Must voluntarily consent. Exclusion Criteria: - Must not have a known history of thiopurine methyltransferase deficiency or family history. - Must not have a history of elevated uric acid or gout. - Must not be currently using allopurinol.


NCT ID:

NCT00602134


Primary Contact:

Principal Investigator
Mark J Allison, MD
MDS Pharma Services


Backup Contact:

N/A


Location Contact:

Phoenix, Arizona 85044
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.